Madaus Laboratories

Madaus is a specialized German pharmaceutical company with a long-standing history in the development of phytopharmaceuticals and synthetic medicinal products. Founded in 1919 by the Madaus brothers, the company became a pioneer in standardized plant-based therapies, most notably through its liver-therapeutic agent Legalon. In 2007, Madaus was acquired by the Italian firm Rottapharm, which was subsequently acquired by Mylan in 2014, eventually becoming part of Viatris in 2020. Today, the Madaus brand remains a significant name in the Viatris portfolio, focusing on therapeutic areas such as gastroenterology, hepatology, and urology. The company maintains a strong presence in the European market with a focus on high-quality manufacturing and evidence-based herbal medicine.